OMASS THERAPEUTICS LIMITED

OMASS THERAPEUTICS LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameOMASS THERAPEUTICS LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 10028228
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of OMASS THERAPEUTICS LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is OMASS THERAPEUTICS LIMITED located?

    Registered Office Address
    Building 4000 John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    England
    Undeliverable Registered Office AddressNo

    What were the previous names of OMASS THERAPEUTICS LIMITED?

    Previous Company Names
    Company NameFromUntil
    OMASS TECHNOLOGIES LIMITEDFeb 26, 2016Feb 26, 2016

    What are the latest accounts for OMASS THERAPEUTICS LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnDec 31, 2024
    Next Accounts Due OnSep 30, 2025
    Last Accounts
    Last Accounts Made Up ToDec 31, 2023

    What is the status of the latest confirmation statement for OMASS THERAPEUTICS LIMITED?

    Last Confirmation Statement Made Up ToMar 12, 2026
    Next Confirmation Statement DueMar 26, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToMar 12, 2025
    OverdueNo

    What are the latest filings for OMASS THERAPEUTICS LIMITED?

    Filings
    DateDescriptionDocumentType

    Confirmation statement made on Mar 12, 2025 with updates

    14 pagesCS01

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of Memorandum and/or Articles of Association

    RES01

    Memorandum and Articles of Association

    61 pagesMA

    Change of share class name or designation

    2 pagesSH08

    Change of share class name or designation

    2 pagesSH08

    Statement of capital following an allotment of shares on Jul 31, 2024

    • Capital: GBP 89,817.693
    4 pagesSH01

    Change of share class name or designation

    2 pagesSH08

    Change of share class name or designation

    2 pagesSH08

    Change of share class name or designation

    2 pagesSH08

    Full accounts made up to Dec 31, 2023

    28 pagesAA

    Confirmation statement made on Mar 12, 2024 with updates

    11 pagesCS01

    Change of share class name or designation

    2 pagesSH08

    Statement of capital following an allotment of shares on Dec 07, 2023

    • Capital: GBP 69,817.693
    4 pagesSH01

    Statement of capital following an allotment of shares on Nov 12, 2023

    • Capital: GBP 69,816.988
    4 pagesSH01

    Change of share class name or designation

    2 pagesSH08

    Change of share class name or designation

    2 pagesSH08

    Change of share class name or designation

    2 pagesSH08

    Accounts for a small company made up to Dec 31, 2022

    21 pagesAA

    Memorandum and Articles of Association

    61 pagesMA

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    RES10
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Appointment of Mr James Arthur Geraghty as a director on May 09, 2023

    2 pagesAP01

    Change of share class name or designation

    2 pagesSH08

    Change of share class name or designation

    2 pagesSH08

    Statement of capital following an allotment of shares on Apr 18, 2023

    • Capital: GBP 69,816.988
    4 pagesSH01

    Confirmation statement made on Mar 21, 2023 with updates

    10 pagesCS01

    Who are the officers of OMASS THERAPEUTICS LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    ASHTON, Christopher Philip
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    Director
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    EnglandBritishDirector133751350001
    BERNSTEIN, Diana
    c/o General Counsel
    7500 Old Georgetown Road
    Suite 850
    20814 Bethesda
    Northpond Ventures
    Maryland
    United States
    Director
    c/o General Counsel
    7500 Old Georgetown Road
    Suite 850
    20814 Bethesda
    Northpond Ventures
    Maryland
    United States
    United StatesAmericanDirector295058460001
    BILLER, Scott, Dr (Phd)
    Gibson Road
    02653 Orleans
    65
    Massachusetts
    United States
    Director
    Gibson Road
    02653 Orleans
    65
    Massachusetts
    United States
    United StatesAmericanExecutive Venture Partner295106530001
    CRESPO-MARTIN, Laia, Phd
    Rue La Boetie
    75008 Paris
    54
    France
    Director
    Rue La Boetie
    75008 Paris
    54
    France
    FranceSpanishPartner At Sanofi Ventures295105880001
    DEEGAN, Rosamond Margaret Chevallier
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    Director
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    EnglandBritishDirector259618960001
    FRANCHIMONT, Nathalie Marie Berthe Michelle
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    Director
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    United StatesBelgianDirector272633150001
    GERAGHTY, James Arthur
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    Director
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    United StatesAmericanCompany Director309026600001
    HODGKIN, Edward Eliot
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    Director
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    EnglandBritishDirector124677600002
    JONIKAS, Magdalena Anna
    Euston Road
    NW1 2BE London
    215
    England
    Director
    Euston Road
    NW1 2BE London
    215
    England
    United KingdomBritishDirector248490870001
    MONTAGU DAOUST, Jonathan Deane
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    Director
    John Smith Drive
    Oxford Business Park South
    OX4 2GX Oxford
    Building 4000
    England
    GermanyBritishDirector260524810001
    HUMM, Roger James
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    Secretary
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    205526760001
    BRISTER, David John
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    Director
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    EnglandBritishDirector134584510004
    HOPPER, Jonathan, Doctor
    Heatley Road
    Oxford Science Park
    OX4 4GE Oxford
    Schrödinger Building
    England
    Director
    Heatley Road
    Oxford Science Park
    OX4 4GE Oxford
    Schrödinger Building
    England
    EnglandBritishDirector206611350001
    HUMM, Roger James
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    Director
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    EnglandBritishChartered Accountant29914990003
    MACKINNON, Lachlan Tom
    Heatley Road
    Oxford Science Park
    OX4 4GE Oxford
    Schrödinger Building
    England
    Director
    Heatley Road
    Oxford Science Park
    OX4 4GE Oxford
    Schrödinger Building
    England
    United KingdomBritishDirector206611400001
    RICHARDS, William Graham, Professor
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    Director
    Begbroke Science Park, Begbroke Hill
    Begbroke
    OX5 1PF Oxford
    Centre For Innovation & Enterprise
    England
    United KingdomBritishUniv Professor51159490001
    ROBINSON, Carol, Professor Dame
    Heatley Road
    Oxford Science Park
    OX4 4GE Oxford
    Schrödinger Building
    England
    Director
    Heatley Road
    Oxford Science Park
    OX4 4GE Oxford
    Schrödinger Building
    England
    EnglandBritishDirector206673140001

    Who are the persons with significant control of OMASS THERAPEUTICS LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Oxford Science Enterprises Plc
    Park End Street
    OX1 1JD Oxford
    King Charles House
    England
    Sep 11, 2018
    Park End Street
    OX1 1JD Oxford
    King Charles House
    England
    No
    Legal FormPublic Limited Company
    Country RegisteredEngland
    Legal AuthorityThe Companies Act 2006
    Place RegisteredEngland And Wales
    Registration Number09093331
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Syncona Limited
    Les Banques
    GY1 3QL St Peter Port
    PO BOX 225 Trafalgar Court
    Guernsey
    Sep 11, 2018
    Les Banques
    GY1 3QL St Peter Port
    PO BOX 225 Trafalgar Court
    Guernsey
    No
    Legal FormLimited Company
    Country RegisteredGuernsey
    Legal AuthorityCompanies (Guernsey) Law 2008
    Place RegisteredGuernsey
    Registration Number55514
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Park End Street
    OX1 1JD Oxford
    King Charles House
    England
    Apr 06, 2016
    Park End Street
    OX1 1JD Oxford
    King Charles House
    England
    Yes
    Legal FormCompany
    Country RegisteredEngland & Wales
    Legal AuthorityCompanies Act 2006
    Place RegisteredCompanies House
    Registration Number09093331
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0